Savara (SVRA) Total Liabilities (2010 - 2026)

Savara (SVRA) reported Total Liabilities of $45.6 million for Q1 2026, up 9.98% year-over-year from $41.5 million in Q1 2025, and down 9.34% quarter-over-quarter from $50.3 million in Q4 2025.

Savara (SVRA) Total Liabilities (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Total Liabilities data on file, last reported at $45.6 million in Q1 2026.

  • Total Liabilities for Q1 2026 came in at $45.6 million, up 9.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.6 million (up 9.98% YoY), and the FY2025 annual result was $50.3 million, up 21.42% from the prior year.
  • Total Liabilities retreated to $45.6 million in Q1 2026 per SVRA's latest filing, from $50.3 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $50.3 million in Q4 2025 and troughed at $29.7 million in Q1 2022.
  • A 5-year average of $37.7 million and a median of $37.2 million in 2023 frame the typical range for Total Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Liabilities decreased 8.54% in 2022, then advanced 21.42% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $32.0 million in 2022, then advanced by 16.23% to $37.2 million in 2023, then increased by 11.39% to $41.4 million in 2024, then increased by 21.42% to $50.3 million in 2025, then retreated by 9.34% to $45.6 million in 2026.
  • Business Quant data shows SVRA's Total Liabilities at $45.6 million in Q1 2026, $50.3 million in Q4 2025, and $46.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.74 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.48 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 731.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 10.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 19.51 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 943,068.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.12 Bn
9 Abivax 91.96 Bn 91.96 Bn - 137.56 Mn
10 Savara 1.39 Bn 1.39 Bn - 45.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 45.61 Mn
Dec 31, 2025 50.30 Mn
Sep 30, 2025 46.54 Mn
Jun 30, 2025 43.28 Mn
Mar 31, 2025 41.47 Mn
Dec 31, 2024 41.43 Mn
Sep 30, 2024 39.47 Mn
Jun 30, 2024 37.94 Mn
Mar 31, 2024 36.43 Mn
Dec 31, 2023 37.19 Mn
Sep 30, 2023 35.53 Mn
Jun 30, 2023 32.12 Mn
Mar 31, 2023 31.10 Mn
Dec 31, 2022 32.00 Mn
Sep 30, 2022 31.24 Mn
Jun 30, 2022 29.74 Mn
Mar 31, 2022 29.73 Mn
Dec 31, 2021 32.10 Mn
Sep 30, 2021 32.05 Mn
Jun 30, 2021 31.05 Mn